Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
depo-medroxyprogesterone acetate
DRUG
2 trials
Sponsors
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
, Centers for Disease Control and Prevention
Conditions
Contraception
HIV
HIV-1 Infection
Phase 2
Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women
Completed
NCT01296152
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
HIV-1 Infection
Start: 2011-05-31
End: 2012-10-31
Updated: 2015-12-22
Phase 4
Clinical Trial on the Effects of Progestin-based Contraception in the Genital Tract of HIV-infected and Uninfected Women
Completed
NCT02103660
Centers for Disease Control and Prevention
Contraception, HIV
Start: 2014-04-08
End: 2017-03-31
Updated: 2018-03-19
Related Papers
Influence of Hormonal Contraceptive Use and HIV on Cervicovaginal Cytokines and Microbiota in Malawi
UNC Libraries
2025-04-08
Influence of Hormonal Contraceptive Use and HIV on Cervicovaginal Cytokines and Microbiota in Malawi.
2023-01-09
8 citations
Depot Medroxyprogesterone Acetate in Combination with a Twice-Daily Lopinavir-Ritonavir-Based Regimen in HIV-Infected Women Showed Effective Contraception and a Lack of Clinically Significant Interactions, with Good Safety and Tolerability: Results of the ACTG 5283 Study
Antimicrobial Agents and Chemotherapy
2015-01-27
19 citations